Get started
AMGEN INCAMGEN INCAMGEN INC

AMGEN INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

AMGNCL chart


Full chart

AMGNCL upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪140.62 T‬ CLP
Dividend yield (indicated)
3.62%
Price to earnings Ratio (TTM)
40
Basic EPS (TTM)
7,110 CLP
Net income (FY)
‪5.92 T‬ CLP
Revenue (FY)
‪24.70 T‬ CLP
Shares float
‪536.25 M‬
Beta (1Y)
0.61

Employees


Employees (FY)
‪26.7 K‬
Change (1Y)
‪+1.5 K‬ +5.95%
Revenue / Employee (1Y)
‪925.10 M‬ CLP
Net income / Employee (1Y)
‪221.85 M‬ CLP

About Amgen Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Robert A. Bradway
Website
amgen.com
Headquarters
Thousand Oaks
Founded
1980
FIGI
BBG00YFS94W4
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

AMGNCL news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

AMGNCL highest yielding bonds


US31162BP4
AMGEN 12/43
Yield to maturity
7.29%
Maturity date
May 15, 2043
AMGN5186584
Amgen Inc. 2.77% 01-SEP-2053
Yield to maturity
7.18%
Maturity date
Sep 1, 2053
AMGN5235280
Amgen Inc. 3.0% 15-JAN-2052
Yield to maturity
6.85%
Maturity date
Jan 15, 2052
US31162CS7
AMGEN 20/50
Yield to maturity
6.77%
Maturity date
Feb 21, 2050
AMGN5235282
Amgen Inc. 2.8% 15-AUG-2041
Yield to maturity
6.67%
Maturity date
Aug 15, 2041
US31162CR9
AMGEN 20/40
Yield to maturity
6.49%
Maturity date
Feb 21, 2040
AMGD
AMGEN 22/52
Yield to maturity
6.49%
Maturity date
Feb 22, 2052
US31162DG2
AMGEN 22/62
Yield to maturity
6.45%
Maturity date
Feb 22, 2062
US31162BZ2
AMGEN 15/45
Yield to maturity
6.35%
Maturity date
May 1, 2045
AMGN4436563
Amgen Inc. 4.663% 15-JUN-2051
Yield to maturity
6.33%
Maturity date
Jun 15, 2051
AMGN4437315
Amgen Inc. 4.563% 15-JUN-2048
Yield to maturity
6.29%
Maturity date
Jun 15, 2048

Explore more bonds 

Sparks


Curated watchlists where AMGNCL is featured.

See all sparks 

Frequently Asked Questions


The current price of AMGNCL is 305,690 CLP — it hasn't changed in the past 24 hours. Watch AMGEN INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BCS exchange AMGEN INC stocks are traded under the ticker AMGNCL.
AMGNCL stock has risen by 15.41% compared to the previous week, the last month showed zero change in price, over the last year AMGEN INC has showed a 32.62% increase.
We've gathered analysts' opinions on AMGEN INC future price: according to them, AMGNCL price has a max estimate of 402,985.07 CLP and a min estimate of 194,029.85 CLP. Watch AMGNCL chart and read a more detailed AMGEN INC stock forecast: see what analysts think of AMGEN INC and suggest that you do with its stocks.
AMGNCL reached its all-time high on Jul 25, 2024 with the price of 323,490 CLP, and its all-time low was 175,410 CLP and was reached on May 25, 2023. View more price dynamics on AMGNCL chart.
See other stocks reaching their highest and lowest prices.
AMGNCL stock is 16.86% volatile and has beta coefficient of 0.61. Track AMGEN INC stock price on the chart and check out the list of the most volatile stocks — is AMGEN INC there?
Today AMGEN INC has the market capitalization of ‪140.34 T‬, it has increased by 1.60% over the last week.
Yes, you can track AMGEN INC financials in yearly and quarterly reports right on TradingView.
AMGEN INC is going to release the next earnings report on Feb 4, 2025. Keep track of upcoming events with our Earnings Calendar.
AMGNCL earnings for the last quarter are ‪5.03 K‬ CLP per share, whereas the estimation was ‪4.76 K‬ CLP resulting in a 5.79% surprise. The estimated earnings for the next quarter are ‪5.01 K‬ CLP per share. See more details about AMGEN INC earnings.
AMGEN INC revenue for the last quarter amounts to ‪7.67 T‬ CLP, despite the estimated figure of ‪7.66 T‬ CLP. In the next quarter, revenue is expected to reach ‪8.80 T‬ CLP.
AMGNCL net income for the last quarter is ‪2.55 T‬ CLP, while the quarter before that showed ‪704.44 B‬ CLP of net income which accounts for 262.25% change. Track more AMGEN INC financial stats to get the full picture.
Yes, AMGNCL dividends are paid quarterly. The last dividend per share was ‪2.20 K‬ CLP. As of today, Dividend Yield (TTM)% is 3.43%. Tracking AMGEN INC dividends might help you take more informed decisions.
AMGEN INC dividend yield was 2.96% in 2023, and payout ratio reached 68.24%. The year before the numbers were 2.95% and 64.07% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 28, 2024, the company has ‪26.70 K‬ employees. See our rating of the largest employees — is AMGEN INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AMGEN INC EBITDA is ‪10.90 T‬ CLP, and current EBITDA margin is 44.11%. See more stats in AMGEN INC financial statements.
Like other stocks, AMGNCL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AMGEN INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AMGEN INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AMGEN INC stock shows the neutral signal. See more of AMGEN INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.